ForSight Raises $ 10 Million to Bring Robotics to Eye Surgery

One of the benefits of surgical robotics is the potential to bring standardized precision to procedures performed almost anywhere and by almost everyone. However, most systems have focused on anything below the neck.

ForSight Robotics aims to bring the same benefits to eye surgery and has raised $ 10 million to embark on building a miniaturized system with the goal of bringing vision correction procedures to a wider population.

The roundtable, supported by Eclipse Ventures and Mithril Capital, will support ForSight’s plans to integrate microsurgical robotics with computer vision and machine learning algorithms, which will study prior eye procedures to help replicate the expertise. owned by ophthalmic surgeons facing high demand – with many countries having only a few to several dozen trained professionals per million people.

“Our goal is to democratize this highly sophisticated procedure, allowing patients around the world to easily access treatment that can restore their vision”, noted ForSight co-founder and CEO Daniel Glozman, who previously held positions at Medtronic Ventor Technologies, Magenta Medical, Diagnostic Robotics and Guide-X.

The company was also co-founded by Moshe Shoham, who previously founded Mazor Robotics prior to its acquisition by Medtronic, and Joseph Nathan, who helped lead healthcare commercialization at the Technion Israel Institute of Technology and led new work at the center Alfred Mann Institute.

Meanwhile, the Israel-based company’s strategic advisory board includes robotics pioneer Fred Moll, MD, co-founder of Intuitive Surgical and Auris Health, as well as Rony Abovitz, co-founder of Mako Surgical and Magic Leap. and Ajay Royan, co-founder of Mithril.

“As populations grow and age, robot-assisted surgery is an essential tool for simultaneously advancing the technique and expanding access to high-level medical expertise,” Royan said. “ForSight’s mission will benefit hundreds of millions of people around the world.

The company’s platform aims to offer surgeons complete freedom of movement while manipulating tools with precise movements on the order of a few microns combined with 3D imaging and real-time guidance.

Source link

Comments are closed.